Breaking News

CellCarta Appoints Dr. Ehab A. El-Gabry as CMO and Head of Companion Diagnostics

El-Gabry brings 25+ years of experience spanning clinical practice, diagnostic medicine, and translational research in oncology and precision diagnostics.

Author Image

By: Charlie Sternberg

Associate Editor

CellCarta, a global CRO laboratory to the biopharmaceutical industry, has appointed Ehab A. El-Gabry, MD, as Chief Medical Officer and Head of Companion Diagnostics. In this role, El-Gabry will provide medical and scientific leadership across CellCarta’s biomarker programs and lead the company’s global pathology organization with a strategic focus on accelerating companion diagnostic (CDx) development and commercialization through digital pathology and AI-enabled image analysis. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters